-
Innovation Ranking
Innovation Ranking – Legend Holdings Corp
Legend Holdings Corp (Legend Holdings) is an investment holding company that makes strategic and financial investments with the aim to generate returns. The company has investments in financial service, innovative consumption, agriculture, food, information technology, advanced manufacturing, and professional services sectors. Legend Holding’s strategic investments focus on long-term returns and on strategic sectors to optimize its portfolio. Through its financial investments, the company focuses on investment opportunities in all development phases of the enterprise and includes angel investment, private equity...
-
Product Insights
NewNet Present Value Model: Legend Biotech Corp’s LB-1908
Empower your strategies with our Net Present Value Model: Legend Biotech Corp's LB-1908 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LCAR-G08 in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LCAR-G08 in Pancreatic Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LCAR-G08 in Pancreatic Cancer Drug Details: LCAR-G08 is under development for...
-
Company Insights
Innovation and Patenting activity of Legend Biotech Corp Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Legend Biotech Corp Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ciltacabtagene Autoleucel in Multiple Myeloma (Kahler Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ciltacabtagene Autoleucel in Multiple Myeloma (Kahler Disease) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ciltacabtagene Autoleucel in Multiple Myeloma (Kahler Disease) Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Onureg in Chronic Lymphocytic Leukemia (CLL)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Onureg in Chronic Lymphocytic Leukemia (CLL) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Onureg in Chronic Lymphocytic Leukemia (CLL) Drug Details: Azacitidine (Onureg)...
-
Analyst Opinions
Blockchain Disruptors in Southeast Asia’s Gaming Landscape
Blockchain Disruptors in Southeast Asia's Gaming Report Overview Blending blockchain with gaming allows startups to provide asset security and true digital ownership. It helps create player-driven ecosystems, and innovative gaming experiences by transforming the traditional gaming market and enhancing player engagement. The growth of blockchain gaming in Southeast Asia (SEA) is fueled by heightened player engagement through real asset ownership, transparent transactions, strong support from government policies, and strategic collaborations and investments. Key Countries ·      Indonesia ·      Myanmar ·      The...
-
Analyst Opinions
Snacks Demand Spaces and Top Trends
Reasons to buy the ‘Snacks Demand Spaces and Top Trends’ report: Gain access to the most impactful snacking trends driven by emerging consumer behavior with the help of GlobalData's TrendSights Framework. Explore and identify how to leverage the top trends in snack demand spaces in 2024. Understand consumer attitudes and behaviors based on the "five Ws": the who, what, when, where, and whys. Understand how innovation programs, new product development, and new concepts and ideas fit into - or challenge...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LB-1908 in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LB-1908 in Gastric Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LB-1908 in Gastric Cancer Drug Details: LB-1908 (LCAR-C18S) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LB-1908 in Esophageal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LB-1908 in Esophageal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LB-1908 in Esophageal Cancer Drug Details: LB-1908 (LCAR-C18S) is under development for...